Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.

Abstract

There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.

DOI: 10.1160/TH09-08-0580

3 Figures and Tables

020040020102011201220132014201520162017
Citations per Year

1,893 Citations

Semantic Scholar estimates that this publication has 1,893 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Lip2010ManagementOA, title={Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.}, author={Gregory Y . H . Lip and Kurt Huber and Felicita Andreotti and Harald Arnesen and Kari Eino Juhani Airaksinen and Thomas Cuisset and Paulus Kirchhof and Francisco Mar{\'i}n}, journal={Thrombosis and haemostasis}, year={2010}, volume={103 1}, pages={13-28} }